Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Janux Therapeutics Inc.

    NASDAQ: JANX · Real-Time Price · USD
    24.70
    -0.83 (-3.25%)
    At close: Aug 19, 2025, 11:59 AM

    Janux Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 10.59M 8.08M 8.61M 3.64M
    Cost of Revenue
    		 2.06M 1.96M 841K 113K
    Gross Profit
    		 8.53M 6.13M 7.77M 3.52M
    Operating Income
    		 -98.85M -72.98M -67.09M -32.93M
    Interest Income
    		 29.85M 14.69M 4.03M 257K
    Pretax Income
    		 -68.99M -58.29M -63.06M -32.67M
    Net Income
    		 -68.99M -58.29M -63.06M -32.56M
    Selling & General & Admin
    		 41.05M 26.14M 22.26M 10.33M
    Research & Development
    		 68.39M 54.92M 53.44M 26.24M
    Other Expenses
    		 -2.06M -1.96M -841K n/a
    Operating Expenses
    		 107.38M 79.11M 74.86M 36.57M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 109.44M 81.06M 75.7M 36.57M
    Income Tax Expense
    		 n/a n/a n/a -113K
    Shares Outstanding (Basic)
    		 53.75M 44.02M 41.47M 41.24M
    Shares Outstanding (Diluted)
    		 53.75M 44.02M 41.47M 41.24M
    EPS (Basic)
    		 -1.28 -1.32 -1.52 -0.79
    EPS (Diluted)
    		 -1.28 -1.32 -1.52 -0.79
    EBITDA
    		 -98.85M -71.02M -66.25M -32.82M
    EBIT
    		 -98.85M -72.98M -67.09M -32.93M
    Depreciation & Amortization
    		 2.06M 1.96M 841K 113K

    Add to Watchlist